NA
NSPR icon

Nottingham Advisors’s InspireMD NSPR Stock Holding History

Nottingham Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,000
Closed -$80.7K – 118
2025
Q1 		$80.7K Hold
30,000
– – 0.01% 115
2024
Q4 		$78.9K Hold
30,000
– – 0.01% 130
2024
Q3 		$80.4K Hold
30,000
– – 0.01% 145
2024
Q2 		$74.9K Hold
30,000
– – 0.01% 154
2024
Q1 		$71.1K Buy
30,000
+5,000
+20% +$13.5K 0.01% 135
2023
Q4 		$70.3K Hold
25,000
– – 0.01% 132
2023
Q3 		$81.8K Hold
25,000
– – 0.01% 126
2023
Q2 		$62.8K Buy
+25,000
New +$39.8K 0.01% 131

Other funds holding NSPR

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nottingham Advisors's NSPR Position: Q2 2025 in Review

Nottingham Advisors sold out of InspireMD (NSPR) in Q2 2025, closing a stake of 30,000 shares — an estimated $80.7K sold.

Nottingham Advisors first reported a position in NSPR in Q2 2023 and held it in 8 quarters. The position peaked at $81.8K in Q3 2023. 36 funds tracked by Wall St. Rank hold NSPR as of Q2 2025.

  • Nottingham Advisors reported no remaining InspireMD position as of Q2 2025 after selling out during the quarter.
  • Nottingham Advisors sold 30,000 InspireMD shares in Q2 2025, an estimated $80.7K.
  • Nottingham Advisors first reported a position in InspireMD in Q2 2023 and held it in 8 quarters.
  • Nottingham Advisors's InspireMD position peaked at $81.8K in Q3 2023.
  • 36 funds tracked by Wall St. Rank held InspireMD as of Q2 2025.

Based on Nottingham Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.